Abstract:
PROBLEM TO BE SOLVED: To provide SMP nucleic acid and protein molecules, which relate to metabolism of carbon compounds such as sugars and generation of energy molecules, in a process (such as oxidative phosphorylation) of Corynebacterium glutamicum. SOLUTION: Isolated nucleic acid molecules of a specific sequence, or a complement thereof, which nucleic acid molecules are selected from a sequence group relating to metabolism of carbon compounds such as sugars and generation of energy molecules, in a process of Corynebacterium glutamicum, are provided, and cells containing the nucleic acid molecules and of genus Corynebacterium or genus Brevibacterium are provided. A method for producing fine chemicals such as an amino acid by using the cells, and a method for detecting existence and activity of Corynebacterium diphtheriae is provided. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a new bacterial nucleic acid molecule having various applications. SOLUTION: Isolated nucleic acid molecules, designated MP (melabolic pathway) nucleic acid molecules, which encode new MP proteins derived from Corynebacterium glutamicum, are described. Antisense nucleic acid molecules, recombinant expression vectors containing MP nucleic acid molecules, and host cells into which the expression vectors are introduced, are also provided. Further, isolated MP proteins, mutated MP proteins, fusion proteins, antigenic peptides and methods for improving production of a desired compound from C. glutamicum based on genetic engineering of MP genes in the organism, are provided. COPYRIGHT: (C)2008,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a stress, resistance and tolerance protein encoding Corynebacterium glutamicum gene used for the discrimination of microorganism for the production of fine chemicals, control of the production of fine chemicals by bacteria, classification or discrimination of bacteria, use as a reference point for the preparation of a genom map and as a label for genetic transformation. SOLUTION: The invention provides an isolated nucleic acid molecule or a designated SRT nucleic acid molecule encoding a new SRT protein derived from Corynebacterium glutamicum. The invention also provides its antisense nucleic acid molecule, a recombinant expression vector containing SRT nucleic acid molecule, and host cell into which the expression vector is to be introduced. The invention still further provides isolated SRT protein, mutated SRT protein, fusion protein, antigenic peptide and method for the improvement of the production of a desired compound from C. glutamicum based on genetic engineering of SRT genes of this organism. COPYRIGHT: (C)2007,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a novel nucleic acid molecule derived from Corynebacterium glutamicum. SOLUTION: Isolated nucleic acid molecules encoding novel PTS proteins (phosphoenolpyruvate: sugar phosphotransferase) derived from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PTS nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated PTS proteins, mutated PTS proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of the PTS genes. COPYRIGHT: (C)2007,JPO&INPIT
Abstract:
Isolated polypeptide sequence having the sequence of SEQ ID NO:1 or muteins thereof having the ability to bind cAMP and repress the expression of the aceB gene of C. glutamicum and which can be obtained from SEQ ID NO:1 by inserting, deleting or substituting up to 20% of the amino acids.
Abstract translation:具有SEQ ID NO:1的序列的分离的多肽序列或其突变蛋白具有结合cAMP的能力并抑制谷氨酸棒杆菌的aceB基因的表达,并且可以通过插入,缺失或替代从SEQ ID NO:1获得 高达20%的氨基酸。
Abstract:
The invention relates to methods for the production by fermentation of sulphur-containing fine chemicals, in particular L-methionine, using bacteria in which a nucleic acid sequence coding for a methionine synthase gene (metF) is expressed.
Abstract:
The invention relates to novel nucleic acid molecules, the use thereof in the construction of bio-engineering improved microorganisms and methods for the production of fine chemicals, especially amino acids with the aid of said bio-engineered improved microorganisms.
Abstract:
The invention relates to a method for producing corynebacteria that contain one or more modified genomic sequences, characterized by using a vector that does not replicate in corynebacteria and whose nucleic acid is not recognized as foreign by the corynebacteria.
Abstract:
Isolated nucleic acid molecules, designated PTS nucleic acid molecules, which encode novel PTS proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PTS nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated PTS proteins, mutated PTS proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of PTS genes in this organism.
Abstract:
The invention relates to poly(ADP-ribose)polymerase (PARP) homologues which are characterised by an amino acid sequence with a) a functional NAD -binding site and b) no zinc-finger-sequence motif of general formula CX2CXmHX2C, wherein m is an integral number 28 or 30 and the radicals X represent any amino acid, independently of each other; and to the functional equivalents of said poly(ADP-ribose)polymerase (PARP) homologues. The invention also relates to nucleic acids coding the poly(ADP-ribose)polymerase (PARP) homologues, to antibodies with specificity for the novel protein, to pharmaceutical and gene therapy agents containing the inventive products, to methods for analytically determining the inventive proteins and nucleic acids, to methods for identifying the effectors or bonding partners of the inventive proteins, to novel PARP effectors and to methods for determining the effectiveness of effectors of this type.